Real-World Data & Evidence — MENA
TH Arabia Data Solutions connects life sciences companies with MENA's healthcare ecosystem — turning ethically sourced, anonymised patient records into decision-grade real-world evidence.
Our ultimate objective is to generate tangible real-world value for life sciences — promoting evidence-based healthcare decision-making and improving patient outcomes across the MENA region.
Ethically sourced, anonymised records from consenting patients across MENA healthcare networks.
Machine learning and validated analytical frameworks that turn raw records into actionable insight.
Full compliance with international data-protection regulations, including GDPR and Saudi PDPL.
Datasets curated to the specific therapeutic area, endpoints, and timeline your study demands.
Our data network spans the GCC and Levant, gathering longitudinal patient data from hospital systems and specialised centres and structuring it to international RWE standards.
From early-phase market access to post-launch pharmacovigilance, TH Arabia Data Solutions supports the full spectrum of life sciences evidence needs.
Generate the HEOR, comparative effectiveness, and safety evidence needed for reimbursement submissions and label extensions in MENA markets.
Access disease-specific cohorts and validate clinical outcomes to support regulatory pathways, value dossiers, and investor reporting.
Benchmark clinical outcomes, identify unmet patient need, and support quality-improvement programmes with longitudinal performance data.
Commission independent population-level analyses on disease burden, treatment patterns, and the economic impact of therapeutic programmes across the region.
TH Arabia Data Solutions supports a wide range of evidence-generation programmes across therapeutic areas and geographies within MENA.
Quantify the direct and indirect costs associated with a condition to support market access, value argumentation, and health-policy dialogue in MENA.
Map real-world prescribing behaviour and compare clinical outcomes across therapeutic options to inform clinical strategy and reimbursement negotiations.
Establish population-level disease estimates and surface gaps in diagnosis, treatment, and follow-up to guide pipeline prioritisation for the MENA market.
Assess how therapies perform in routine clinical care — tracking response rates, adverse events, healthcare utilisation, and cost of care over time.
Evaluate the clinical impact and return on investment of disease-management programmes — from adherence support to remote-monitoring initiatives.
Complement spontaneous reporting with population-level signal detection — tracking drug-event associations in real-world MENA patient populations.
Beyond our standard evidence programmes, TH Arabia Data Solutions designs and delivers bespoke analytical monitors and live dashboards — calibrated to your therapeutic area, endpoints, and reporting cadence.
Flagship Data Partner
Istanbul, Türkiye — part of IHH Healthcare Group
Acibadem Healthcare Group is one of the largest private healthcare providers in the region and a cornerstone of the TH Arabia Data Solutions network. Through a data-sharing agreement that meets international privacy standards, Acibadem contributes longitudinal patient records across its 25 hospitals, 60+ specialised centres, and 18 outpatient clinics — covering oncology, cardiology, endocrinology, and a broad range of other therapeutic areas.
This partnership gives life sciences clients unprecedented depth of clinical insight into a diverse, high-volume patient population — bridging the gap between clinical trial evidence and real-world care delivery in MENA and beyond.
Working with TH Arabia Data Solutions gave us access to the kind of granular, longitudinal patient data that simply does not exist anywhere else in the region. The team's rigour in data governance and their understanding of our evidence requirements meant we could go from question to analysis in a fraction of the time we were used to.
We combine regional expertise, clinical data depth, and analytical rigour to deliver evidence that stands up to regulatory, payer, and scientific scrutiny.
Our partner network was built specifically for the GCC and Levant — delivering population-representative data that global datasets cannot replicate.
End-to-end data governance — from consent and anonymisation at source to access-controlled delivery — ensuring full compliance with GDPR and Saudi PDPL.
Our analytical frameworks are peer-reviewed and aligned with ISPE, ISPOR, and EMA guidelines for real-world data studies.
Pre-structured datasets and established data agreements with partner institutions mean feasibility-to-data in weeks, not months.
A team with deep knowledge of MENA healthcare systems, regulatory environments, and commercial market dynamics across the GCC and Levant.
From full study reports to live analytical dashboards, we structure our outputs to fit your internal workflows, regulatory timelines, and stakeholder requirements.
Whether you are scoping a new evidence programme, exploring a data partnership, or looking for a bespoke analytical monitor — we would be glad to hear from you.
Tell us about your evidence programme — therapeutic area, study objectives, and timeline — and we will come back with a feasibility assessment.
Write to usHealthcare providers and data holders interested in joining the TH Arabia Data Solutions network are welcome to reach out directly.
Write to usDescribe your therapeutic area and analytical requirements and we will scope a tailored dashboard or monitoring programme for you.
Write to us